Skip to content
CHI Podcasts cover art

All Episodes

CHI Podcasts — 255 episodes · page 1 of 3

#
Title
1

Molecular Med Tri-Con 2020 | Artificial Intelligence in Precision Medicine

2

Molecular Med TriCon 2019 | Gene Therapy for Rare Disorders

3

Immunogenicity Summit 2019 | From Cell & Gene Therapy to Biostatistics

4

Next Generation Dx 2019 | Launch a Paradigm Shift through an Innovative Diagnostic Test

5

the Liquid Biopsy Summit 2019 | Reimagining Liquid Biopsy Applications with Epigenomics

6

Molecular DX Europe 2019 | Using Point-of-Care Diagnostics to Advance a One Health Approach

7

Molecular Med Tri-Con 2019 | Putting the AI in Wait

8

Molecular Med Tri-Con 2019 | Real Precision Medicine is Starting with the Patient

9

Molecular Med Tri-Con 2019 | Target the Tumor Mutational Burden and Pursue Harmonization

10

PEGS Boston 2019 | Jennifer Chadwick’s Story of Building a Creative and Authentic Career in Science

11

Bio-IT World | Advancing Life Sciences Research: Accelerating innovation in the age of cloud

12

Molecular Med Tri-Con 2019 | Personalized Estimation of Motality Risk

13

Information Technology in Support of Genetics in the Clinic

14

Leveraging Health Information Exchange to Achieve Population Health Surveillance

15

Population Segmentation and Care Management in R&D of New Therapeutics

16

Discovery on Target 2018 | Reprogramming Tumor Microenvironment to Enhance Immunotherapy

17

Discovery on Target 2018 | Novel Strategies to Produce Better NK Cells for Cancer Treatment

18

Discovery on Target 2018 | Engineering NK Cells for Enhanced Potency and Persistence

19

PEGS Europe 2018 | Transient Protein Gene Expression and Biotherapeutics

20

Bispecific Antibody Pipeline Congress 2018 | Checkpoint-binding Bispecific Antibodies

21

Next Generation DX Summit 2018 | Challenges and Opportunities in Molecular Testing

22

Next Generation Dx 2018 | Dissecting Liquid Biopsy in MBC

23

Next Generation Dx Summit 2018 | Molecular Diagnostics in Precision Medicine and Healthcare

24

Next Generation DX Summit 2018 | the Value of NGS-based Diagnostic Testing for Lung Cancer Patients

25

Next Generation DX Summit 2018 | Developing Low Cost Diagnostics for Infectious Disease

26

Next Generation DX Summit 2018 | Rapid Fire: Getting to Know Suman Bose

27

Bio-IT World Expo 2018 | AI and Machine Learning for Healthcare

28

Bio-IT World Expo 2018 | Gene Discovery and Clinical Impact

29

Bio-IT World Expo 2018 | High-Speed Scientific Data Transfers, Scalability Impact on Security

30

Molecular Diagnostics Europe 2018 | Advances in Sepsis Diagnostics: the HostDx Sepsis Platform

31

World Preclinical Congress 2018 | Next-Generation Screening Platforms: BBB Organoids and Beyond

32

PEGS Boston 2018 | Building a Single Donor Phage Antibody Library with NGS Validation

33

Molecular Diagnostics Europe 2018 | The Changing Regulatory Requirements in the EU

34

Molecular Diagnostics Europe 2018 | The Role of Epigenetics in Circulating Tumour Cells

35

Molecular Diagnostics Europe 2018 | Addressing Challenges in cfDNA Analysis

36

Harnessing the power of Big Data and AI for faster, better, and more efficient studies

37

PEGS Boston 2018 | Discovery of High-Affinity Human PD-1 and LAG-3 Antibodies

38

Molecular Diagnostics Europe 2018 | Cell-Based NIPD: Where Are We Now and Where Are We Going?

39

Molecular Diagnostics Europe 2018 | The New EU IVD Regulation – What Will It Mean for Your Lab?

40

PEGS Boston 2018 | Challenges and Opportunities in the Next Generation of Bioassays for Biologics

41

PEGS Boston 2018 | How to Interpret and Implement FDA Guidelines for Biologics?

42

PEGS Boston 2018 | An interview with the 2018 Young Scientist Keynote, Dr. Kipp Weiskopf

43

SCOPE 2018 | Clinical Trial Contracting Challenges

44

PepTalk 2018 | Remodeling of Cell Surfaceomes in Cancer

45

ImPACT 2017 | Targeting the Hypoxic Tumor Microenvironment

46

Bio-IT World | Accelerate Real World Evidence: Leveraging Data for Faster Time to Insight

47

ImPACT 2017 | What Will the IMPACT of the Microbiome be on Cancer Immunotherapy?

48

Advances in Prenatal Molecular Diagnostics 2017 | Fetal Whole Exome Sequencing

49

PEGS Europe 2017 | The Next Generation of Antibody-Drug Conjugates (ADCs)

50

Discovery on Target 2017 | Small Molecule Ubiquitin Protease (USP7) Inhibitors

51

Discovery on Target 2017 | Targeted Platform for RNA Therapeutics

52

Discovery on Target 2017 - PROTACs: The Chemical Equivalent of CRISPR

53

Next Generation Dx 2017 | Wild West: Exome Sequencing in the Clinic

54

IMPACT 2017 | Parker Institute for Cancer Immunotherapy -Tumor Epitope Selection Alliance (TESLA)

55

Biobanking Congress 2017 | Biobank Sustainability and the Upstream Impact of Clinical Care

56

Biobanking Congress 2017 | Observations on the Post-Mortem Tissue Donation for Biospecimen Research

57

Next Generation Dx Summit 2017 | Molecular Diagnostics in Antibiotics Stewardships Programs

58

Next Generation Dx Summit 2017 | Point-of-Care Devices in Immunotherapy and Beyond

59

Next Generation Dx Summit 2017 | Point-of-Care Devices in Liquid Biopsy

60

Molecular Med Tri-Con 2017 | Development of Novel Diagnostic Tests

61

Molecular Med Tri-Con 2017 | Diagnostics World Early Innovator Award Interview

62

Next Generation Dx Summit 2017 | The Microbiome’s Diagnostic Potential

63

Next Generation Summit 2017 | NGS in DNA Forensics: Benefits, Challenges, and Future Potential

64

World Preclinical Congress 2017 | Need for Translational Methods in CNS Drug Discovery

65

Next Generation Dx Summit 2017 | Predicting Responses to Cancer Immunotherapy

66

Next Generation Dx Summit 2017 | Geisinger’s Strategy for Clinical NGS Implementation

67

Next Generation Dx Summit 2017 | Precision Medicine Outside of Oncology

68

Next Generation Dx Summit 2017 | Implementing Point-of-Care Testing and Pharmacogenetic Testing

69

Next Generation Dx Summit 2017 | Genome Sequencing Clinical Applications

70

Next Generation Dx Summit 2017 | Reimbursement of Companion Diagnostics

71

Next Generation Dx Summit 2017 | Walking Down Evidence Street™: Where the Market Meets Evidence

72

World Preclinical Congress 2017 | Next-Generation Human Body-on-a-Chip Systems

73

Biodefense World Summit 2017 | Empowering Rapid Diagnostics with Sample Preparation Methodologies

74

PEGS Boston 2017 | Generation of BiKEs and TriKEs

75

Molecular Med Tri-Con 2017 | Targeted NGS Panel in Autism Spectrum Disorders

76

World Preclinical Congress 2017 | Cancer Therapeutics – Advice for the Future

77

Strategic Alliance Management Congress 2017 | The Evolution and Challenges of Biopharma Alliances

78

Medical Informatics World 2017 | Leveraging Novel Technologies to Improve Patient Access

79

Bio-IT World Expo 2017 | Data Security Standards for Drug R&D

80

Liquid Biopsy Summit 2017 | Cancer Metastasis

81

PEGS Boston 2017 | Development on Novel Therapeutic Antibodies

82

Bio-IT World | Strategic Challenges in the Bio IT Infrastructure Landscape

83

Medical Informatics World 2017 | What Is Necessary to make Telehealth Standard of Care?

84

World Preclinical Congress 2017 | Developing Microfluidics

85

PEGS Boston 2017 | Future Directions for HX-MS in Formulation Development and Similarity Assessment

86

Bio-IT World Expo 2017 | Genomic Medicine: Bioinformatics, Whole Genomes and the Future of the Field

87

Clinical Trial Innovation Summit 2017 | The Need for Collaboration and Performance Metrics

88

Molecular Diagnostics Europe 2017 | Immune Monitoring in Next Generation Immunotherapy Trials

89

Clinical Trial Innovation Summit 2017 | Lessons Learned from a Pharma and CRO Perspective

90

PEGS Boston 2017 | New Technology on Multiplex ADA Isotyping

91

Bio-IT World Expo 2017 | The Future of IT in the World of Big Data

92

PEGS Boston 2017 | Preventing Toxicity in CAR T Cell Therapy

93

Molecular Med Tri-Con 2017 | NIPT: Ethical Implications and Trends Toward Precision Medicine

94

PEGS Boston 2017 | The Promise of Neoantigens for Personalized Cancer Vaccines

95

Molecular Med Tri-Con 2017 | Early Detection of Cancer: Myth or Reality?

96

PEGS Boston 2017 | Programming Proteins by Deep Sequencing and Design

97

Bio-IT World 2017 | Scalable Systems for Data Visualization: Current and Future Challenges

98

Molecular Diagnostics Europe 2017 | Redefining the Set of Solutions for Antibiotics Misuse

99

Molecular Diagnostics Europe 2017 | Point-of-Impact Testing in the Emergency Department

100

Molecular Med Tri-Con 2017 | The Future of Bioinformatics in Personalized & Precision Medicine